LEADER 03490nam  22006492  450 
001 9910782968303321
005 20151005020623.0
010   $a1-107-11115-3
010   $a1-280-15888-3
010   $a9786610158881
010   $a0-511-11716-7
010   $a0-511-00597-0
010   $a0-511-14908-5
010   $a0-511-30292-4
010   $a0-511-54416-2
010   $a0-511-05128-X
035   $a(CKB)1000000000003511
035   $a(EBL)144648
035   $a(OCoLC)437072460
035   $a(SSID)ssj0000166469
035   $a(PQKBManifestationID)11164924
035   $a(PQKBTitleCode)TC0000166469
035   $a(PQKBWorkID)10161514
035   $a(PQKB)11046298
035   $a(UkCbUP)CR9780511544163
035   $a(MiAaPQ)EBC144648
035   $a(Au-PeEL)EBL144648
035   $a(CaPaEBR)ebr2000719
035   $a(CaONFJC)MIL15888
035   $a(PPN)261332384
035   $a(EXLCZ)991000000000003511
100   $a20090506d1999||||  uy|            0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 12$aA guide to the extrapyramidal side-effects of antipsychotic drugs /$fD.G. Cunningham Owens$b[electronic resource]
210  1$aCambridge :$cCambridge University Press,$d1999.
215   $a1 online resource (x, 351 pages) $cdigital, PDF file(s)
300   $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
311   $a0-521-63353-2 
320   $aIncludes bibliographical references (p. 320-345) and index.
327   $aPreliminaries; Contents; Preface; 1 The background; 2 Some preliminaries; 3 Acute dystonias; 4 Parkinsonism; 5 Akathisia; 6 Tardive dyskinesia; 7 Tardive and chronic dystonia; 8 Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 9 Special populations; 10 The clinical examination; 11 An overview of some standardised recording instruments; 12 Some medicolegal and quality-of-care issues; References; Index
330   $aAntipsychotic drugs have revolutionised the management of major psychiatric disorders and the outcomes of those who suffer from them. They are, however, possessed of a range of adverse effects, amongst the most frequent and distressing of which are those resulting in disturbance of voluntary motor function. Extrapyramidal side effects - or E.P.S. - are still poorly recognised and not infrequently misattributed. Despite a vast research literature, there have been few attempts to bring together both the descriptive clinical elements of these disorders and major research conclusions pertinent to routine practice. This very readable and well illustrated 1999 book seeks to rectify this in the hope of increasing clinicians' awareness of the issues and acknowledgement of their impact. This is a task made more rather than less urgent with the emergence of drugs of lower liability but which may promote subtler abnormality than standard compounds.
606   $aExtrapyramidal disorders
606   $aAntipsychotic drugs$xSide effects
615  0$aExtrapyramidal disorders.
615  0$aAntipsychotic drugs$xSide effects.
676   $a616.8/3
700   $aOwens$b D. G. Cunningham$g(David Griffith Cunningham),$f1949-$01498000
801  0$bUkCbUP
801  1$bUkCbUP
906   $aBOOK
912   $a9910782968303321
996   $aA guide to the extrapyramidal side-effects of antipsychotic drugs$93723356
997   $aUNINA